Defining Discontinuation for Buprenorphine Treatment: Implications for Quality Measurement

Williams, A. R., Mauro, C. M., Huber, B., Chiodo, L., Crystal, S., Samples, H., & Olfson, M. (2024). Defining Discontinuation for Buprenorphine Treatment: Implications for Quality Measurement. American Journal of Psychiatry, 181(5), 457–459. https://doi.org/10.1176/appi.ajp.20230808
Authors:
Arthur Robin Williams
Christine M Mauro
Ben Huber
Lisa Chiodo
Stephen Crystal
Hillary Samples
Mark Olfson
Affiliated Authors:
Arthur Robin Williams
Christine M Mauro
Ben Huber
Lisa Chiodo
Stephen Crystal
Hillary Samples
Mark Olfson
Columbia Affiliation:
Subjects:
Buprenorphine (MeSH)
Opioid-Related Disorders (MeSH)
Opiate Substitution Treatment (MeSH)
Author Keywords:
buprenorphine
discontinuation
medication for opioid use disorder
opioid use disorder
pharmacoepidemiology
elink
Publication Type:
Article
Unique ID:
10.1176/appi.ajp.20230808
PMID:
38706334
DOI:
10.1176/appi.ajp.20230808
Journal:
American Journal of Psychiatry
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: